Anti-Ageing Drugs Market by Drug Class (Serums & Supplements, Antioxidants And Enzymes, Stem Cells and Drugs) with Top 10 Players Till 2023

“Anti-Ageing Drugs Market”
The Global Anti-Ageing Drugs Market is driven by factors such as the rising number of ageing population, growing demand for anti-aging drugs, influence of media and fashion industry, and growing demand to be young and healthy.

Anti-Ageing Drugs Market Overview:

The Global Anti-Ageing Drugs Market is expected to reach USD 124,896.6 million by 2023, and the market is projected to grow at a CAGR of ~ 13.3 % during the forecast period 2017-2023. The Global Anti-Ageing Drugs Industry is driven by factors such as the rising number of ageing population, growing demand for anti-aging drugs, influence of media and fashion industry, and growing demand to be young and healthy. Thus, being young is the primal desire of humans from time immemorial.

Critical market constraints are scepticism, concerns of safety, stringent regulations and definition ambiguity etc. Many nutritional products with dubious claims are easily available on the web, that has spurred a flood of self-proclaimed experts proposing growth hormones, skin-care products, beta glucan, and a variety of dietary and nutritional supplements with claims that are difficult to validate. This concern has been expressed by many citizen bodies as well as media. Numerous cosmetics have been included or claimed to have anti-aging effects and have been termed as cosmeceuticals. The Food and Drug Administration has repeatedly warned many producers of anti-ageing medicines of such claims.

Get Exclusive Sample Copy @ https://www.marketresearchfuture.com/sample_request/3504 .

Key Players in the Global Anti-Ageing Drugs Market

Nu Skin,

BIOTIME, INC.,

Elysium Health Inc.,

La Roche-Posay,

DermaFix,

L’ORÉAL, and others.

Thus, counterfeit products are a menace in the anti-ageing products which reduces the market for quality products from reputed manufacturers. Misbranding is another issue, as many supplements have been branded as having an anti-ageing effect based on unreliable sources. Thus brand awareness and brand loyalty plays a critical role in the global anti-ageing drugs market. Established market players must focus on experimental studies to validate the claims made by the product. Maintaining market equity is of utmost importance as the market is highly integrated and specialized. Lack of any effective drug is likely to make any novel drug an immediate market leader with minimal marketing cost and efforts.

Key Findings:

Serums and supplements segment commanded the largest market share in 2016 and is expected to reach USD 51,590.5 million by the end of 2023. Furthermore, stem cells segment is expected to be the fastest growing market which is expected to grow at a CAGR of 16.6 % during the forecast period 2017-2023

Skin and hair segment commanded the largest market share in 2016. This market is expected to reach USD 72,222.3 million by 2023, at a CAGR of 15.9 % during the forecast period 2017-2023

North America held the largest market share in 2016. This market is expected to reach USD 42,470.5 million by 2023, at a CAGR of 13.4 % during the forecast period of 2017-2023

Segments

The global anti-ageing drugs market has been segmented on the basis of drug class and applications. On the basis of drug class, the market is segmented into serums and supplements, antioxidants and enzymes, stem cells and drugs. On the basis of application, the market is segmented into skin and hair, skeletal and muscles, age related disorders and others.

Regional Analysis

The Americas holds a significant market share followed by Europe. The high per capita income of the US, the presence of large innovative players in healthcare of the US regions drive the anti-ageing drugs market. The ageing population of baby boomers is expected to propel the market in the US. North America lead the global anti-ageing drugs market with revenue of USD 42,470.5 million in 2016.

Europe is the second largest market in the globe due to a high healthcare expenditure and influence of media industry.

Asia Pacific region is expected to grow rapidly; Japan, China and India are likely to lead the market due to unmet needs during the forecasted period. APAC is expected to grow at a higher CAGR of 15.3 % than the other regions because of increasing ageing population in this region.

Gulf nations such as Saudi Arabia and the UAE drive the Middle East & African market. The African region is expected to witness a moderate growth owing to poor economic and political conditions and poor healthcare development.

Major TOC For Anti-Ageing Drugs Market Research Report- Global Forecast till 2023:

1 Report Prologue

2 Introduction

2.1 Definition

2.2 Scope Of Study

2.3 Research Objective

2.4 Assumptions & Limitations

2.4.1 Assumptions

2.4.2 Limitations

2.5 Market Structure

3 Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

4 Market Dynamics

4.1 Drivers

4.1.1 Rising Ageing Population

4.1.2 Primal Desire Of Humans To Remain Young

4.1.3 Influence Of Lifestyle Industry And Rising Awareness

4.1.4 High Levels Of Disposable Incomes

4.2 Restraints

…TOC Continued

Ask Questions to Expertise @ https://www.marketresearchfuture.com/enquiry/3504 .

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/anti-ageing-drugs-market-3504